Financhill
Sell
44

MRCY Quote, Financials, Valuation and Earnings

Last price:
$45.25
Seasonality move :
2.32%
Day range:
$45.10 - $46.39
52-week range:
$26.48 - $52.25
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.98x
P/B ratio:
1.85x
Volume:
1M
Avg. volume:
508.8K
1-year change:
57.97%
Market cap:
$2.7B
Revenue:
$835.3M
EPS (TTM):
-$1.55

Earnings Data

Next earnings date for MRCY
May 07
2025
Most recent earnings per share
-$0.30
Missed by $0.26
(Feb 4/2025)
Consensus Estimate
-$0.04
(Feb 4/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MRCY Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/07/2025 Q1 $204.2M -- -- $0.06 --
02/04/2025 Q4 $182.4M $223.1M -$0.30 -$0.04 -$0.26
11/05/2024 Q3 $181.8M $204.4M -$0.30 -$0.08 -$0.22
08/13/2024 Q2 $230.5M $248.6M -$0.18 -$0.04 -$0.14
05/07/2024 Q1 $214.5M $208.3M -$0.77 -$0.06 -$0.71
02/06/2024 Q4 $207M $197.5M -$0.79 $0.08 -$0.87
11/07/2023 Q3 -- -- -$0.64 $0.17 -$0.81
08/15/2023 Q2 -- -- -$0.15 $0.59 -$0.74
05/02/2023 Q1 -- -- $0.09 $0.36 -$0.27
01/31/2023 Q4 -- -- -$0.19 $0.32 -$0.51
11/01/2022 Q3 -- -- -$0.26 $0.21 -$0.47
08/02/2022 Q2 -- -- $0.30 $0.98 -$0.68
05/03/2022 Q1 -- -- $0.07 $0.58 -$0.51
02/01/2022 Q4 -- -- -$0.05 $0.42 -$0.47
11/02/2021 Q3 -- -- -$0.13 $0.40 -$0.53
08/03/2021 Q2 -- -- $0.32 $0.68 -$0.36
05/04/2021 Q1 -- -- $0.28 $0.62 -$0.34
02/02/2021 Q4 -- -- $0.23 $0.51 -$0.28
11/03/2020 Q3 -- -- $0.29 $0.47 -$0.18
08/04/2020 Q2 -- -- $0.49 $0.57 -$0.08
04/28/2020 Q1 -- -- $0.43 $0.52 -$0.09
01/28/2020 Q4 -- -- $0.29 $0.48 -$0.19
10/29/2019 Q3 -- -- $0.35 $0.41 -$0.06
07/30/2019 Q2 -- -- $0.47 $0.44 $0.03
04/30/2019 Q1 -- -- $0.50 $0.45 $0.05
01/29/2019 Q4 -- -- $0.47 $0.42 $0.05
10/30/2018 Q3 -- -- $0.39 $0.35 $0.04
07/31/2018 Q2 -- -- $0.47 $0.42 $0.05
04/24/2018 Q1 -- -- $0.30 $0.35 -$0.05
01/23/2018 Q4 -- -- $0.28 $0.30 -$0.02
10/24/2017 Q3 -- -- $0.37 $0.26 $0.11
08/01/2017 Q2 -- -- $0.32 $0.29 $0.03
04/25/2017 Q1 -- -- $0.29 $0.28 $0.01
01/23/2017 Q4 -- -- $0.24 $0.10 $0.14
10/25/2016 Q3 -- -- $0.17 $0.04 $0.13
08/02/2016 Q2 -- -- $0.25 $0.15 $0.10
04/26/2016 Q1 -- -- $0.13 $0.14 -$0.01
01/26/2016 Q4 -- -- $0.14 $0.12 $0.02
10/27/2015 Q3 -- -- $0.14 $0.07 $0.07
08/04/2015 Q2 -- -- $0.19 $0.12 $0.07
04/28/2015 Q1 -- -- $0.18 $0.13 $0.05

Mercury Systems Earnings Questions

  • How Much did Mercury Systems Generate in Revenue Last Quarter?

    Mercury Systems reported $223.1M worth of top line sales in its most recent quarter.

  • Did Mercury Systems Beat Earnings Last Quarter?

    Mercury Systems announced earnings per share of -$0.30 which represents a miss of analyst forecast a -$0.04 per share.

  • Is Mercury Systems Profitable?

    Mercury Systems reported $60.8M that represents $1.04 per share over the last quarter.

  • What is the Analyst Consensus for Mercury Systems EPS Next Year?

    Mercury Systems's earnings are forecast to decrease from -$2.38 per share to $0.39 per share next year representing a decrease of -91.93%.

  • When is Mercury Systems's Earnings Date?

    Mercury Systems's next earnings date is May 7, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is CyberArk Stock a Buy, Sell or Hold?
Is CyberArk Stock a Buy, Sell or Hold?

CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…

Is Amazon Stock Still Worth Staking On?
Is Amazon Stock Still Worth Staking On?

Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…

Is Palantir a Good Stock to Buy?
Is Palantir a Good Stock to Buy?

Palantir Technologies (PLTR) stock soared to its highest level in…

Stock Ideas

Buy
55
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Sell
50
RGC alert for Mar 22

Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.

Sell
36
VMI alert for Mar 22

Valmont Industries [VMI] is down 12.54% over the past day.

Buy
61
ALNY alert for Mar 22

Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock